(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * U.S. job growth slows in April * Apple jumps after announcing record share buyback * Expedia slides after trimming FY revenue growth forecast * Futures up: Dow 1.29%, S&P 1.14%, Nasdaq 1.61% (Updated at 8:42 a.m. ET/1242 GMT) By Shristi Achar A and Shashwat Chauhan May 3 (Reuters) - Wall Street's main indexes were set to open higher on Friday after a softer-than-expected jobs report revived hopes of the Federal Reserve cutting interest rates this year, while gains in Apple and Amgen on upbeat corporate updates added support. The Labor Department report showed U.S. nonfarm payrolls increased by 175,000 jobs in April, compared with expectations for an increase of 243,000, according to economists polled by Reuters. The unemployment rate stood at 3.9% compared with expectations that it would remain steady at 3.8%, while average earnings rose 0.2% on a monthly basis against forecasts of 0.3% growth. "The data is soft across the board from the Fed's perspective, which is what really matters and an unemployment rate of 3.9% is not something disastrous," said Jason Pride, chief of investment strategy and research at Glenmede. "This indicates an economy that is not declining dramatically, but it definitely indicates a looser labor market." Money markets are pricing in about 51 basis points of rate cuts from the U.S. central bank this year, compared with about 41 bps prior to the data release, according to LSEG data. The latest economic data follows the Federal Reserve's more dovish-than-expected interest rate guidance in its latest policy meeting, which caused U.S. stocks to rally on Thursday. Apple jumped 7.2%, outpacing other megacap stocks in premarket trading on Friday after the iPhone maker unveiled a record $110 billion share buyback program and beat modest expectations for quarterly results and forecast. Amgen climbed 12.9% as the biotechnology firm said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide and as it reported first-quarter earnings. Shares of rival Eli Lilly dipped 1%, while weight-loss drug developer Viking Therapeutics shed 2.3%. At 08:42 a.m. ET, Dow E-minis were up 497 points, or 1.29%, S&P 500 E-minis were up 58.25 points, or 1.14%, and Nasdaq 100 E-minis were up 284 points, or 1.61%. Block rose 9.4% after the Jack Dorsey-led payments fintech firm lifted its full-year adjusted core earnings forecast and revealed plans to add more bitcoins to its balance sheet. Expedia fell 10.5% after the online travel agency cut its full-year revenue growth forecast as gross bookings were hit by a drag in its vacation rental platform. Fortinet dipped 7.8% after the cybersecurity firm forecast second-quarter billings below Wall Street estimates. (Reporting by Shristi Achar A and Shashwat Chauhan in Bengaluru, Additional reporting by Ankika Biswas; Editing by Shounak Dasgupta)
US STOCKS-Wall St set to open sharply higher on soft jobs data
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...